Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
This study is researching an experimental drug called ubamatamab, also referred to as "study drug". The study is focused on patients who have advanced ovarian cancer. The aim of the study is to see how safe, tolerable, and effective the study drug is on its own and in combination with other anti-cancer drugs (bevacizumab, cemiplimab, fianlimab and a standard chemotherapy drug, pegylated liposomal doxorubicin \[PLD\]), referred to as "combination drugs'. The study is looking at several other re
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this ovarian cancer clinical trial in Birmingham, AL
If you're searching for ovarian cancer treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.